Secarna: leading in antisense oligonucleotides
With a growing product portfolio, Munich-based biotech company Secarna Pharmaceuticals focuses on developing so-called antisense oligonucleotide drugs, or ASOs. These drugs are used, for example, within immunoncology and in the treatment of inflammation and fibrosis. In addition, Secarna is working with partners to develop ASOs for numerous other medical applications.
Continue reading